Enteropathic Arthritis
On this page
Direct answer
Enteropathic arthritis affects roughly 5–20% of patients with inflammatory bowel disease and splits into two peripheral patterns plus an axial one. Type 1 is an oligoarticular, lower-limb, large-joint arthritis that parallels bowel inflammation; Type 2 is a polyarticular small-joint arthritis that runs its own course independent of the gut. Axial disease (sacroiliitis, spondyloarthritis) is also independent of bowel activity, which is why treating the joints and treating the bowel must be planned together for NEET-PG Medicine questions.
What you must remember
- Type 1: fewer than five joints, knees and ankles typical, flares with bowel relapses, heals without erosion or deformity.
- Type 2: five or more joints, small joints of hands, persists regardless of bowel activity.
- Peripheral enteropathic arthritis is non-erosive and non-deforming — a classic differentiator from rheumatoid arthritis.
- NSAIDs can trigger a flare of underlying IBD; if unavoidable, a COX-2 selective agent with a proton pump inhibitor is preferred for the shortest possible time.
- Infliximab, adalimumab, golimumab (ulcerative colitis) and certolizumab treat both gut and joints.
- Etanercept fails to heal the bowel and may unmask de novo IBD; anti-IL-17 agents (secukinumab) are contraindicated because they can provoke new-onset IBD.
- Erythema nodosum and peripheral arthritis both track bowel activity, whereas pyoderma gangrenosum and uveitis do not reliably do so.
- First-line steroid-sparing options that also help the bowel include azathioprine, 6-mercaptopurine and methotrexate.
How to work through a typical case
A 26-year-old man with ileal Crohn's disease returns with a swollen right knee and a dull ache in both ankles over three weeks. Step one: confirm this is inflammatory, not septic — an unmarried young man with known IBD and an asymmetric oligoarthritis of the lower limb is far more likely to have Type 1 peripheral arthritis, but a joint aspiration to exclude infection is still sound practice when a single joint is hot and swollen.
Step two: ask about the bowel. Increased stool frequency, blood or colicky pain suggests a luminal flare, and the arthritis will usually settle when the bowel is treated. Step three: review his current therapy. If he has been managing flares with diclofenac self-medication, that NSAID may be feeding both problems — replace it with paracetamol or short-course low-dose steroids, and plan maintenance with azathioprine.
Step four: if joint disease recurs despite bowel control, escalate thoughtfully. Choose a monoclonal anti-TNF (infliximab or adalimumab) rather than etanercept, and never choose anti-IL-17 therapy in a patient with IBD. Step five: screen for axial involvement — morning stiffness over thirty minutes, buttock pain alternating sides, and reduced lateral lumbar flexion — because sacroiliitis demands physiotherapy and independent follow-up. Finally, check for the extraskeletal associations examiners love: clubbing of the fingers in active Crohn's, erythema nodosum over the shins, and a history of uveitis presenting as a painful red eye with photophobia.
Where students slip
The commonest error is treating the joint in isolation. A question stem describing "a patient with ulcerative colitis on regular ibuprofen for knee pain, now with worsening diarrhoea and blood" is testing whether you know that NSAIDs exacerbate IBD — the right answer is to stop the NSAID, not to add a disease-modifying drug. The second trap is the biologic question: "Which anti-TNF can be used in a patient with Crohn's disease and arthritis?" Etanercept looks attractive because it treats other spondyloarthritides, but it is the wrong answer here. Similarly, a stem pairing secukinumab with resolving diarrhoea is bait for the IL-17/IBD contraindication. Remember also that pouchitis after colectomy responds to metronidazole or ciprofloxacin — a surgery-linked viva favourite.
Frequently asked questions
Which type of enteropathic arthritis parallels bowel disease activity?
Type 1 peripheral arthritis does. It is an oligoarticular, large-joint, lower-limb arthritis that flares with luminal relapses and resolves without erosion as the bowel settles.
Why is etanercept avoided in enteropathic arthritis?
Etanercept does not heal intestinal inflammation and has been associated with new-onset inflammatory bowel disease. Monoclonal antibodies such as infliximab and adalimumab control both gut and joints.
Can NSAIDs be used for joint pain in ulcerative colitis?
They should be avoided where possible because they may trigger a colonic flare. Short-term COX-2 selective use with gastroprotection is the compromise when unavoidable.
Is peripheral enteropathic arthritis deforming?
No. Unlike rheumatoid arthritis, both peripheral types are non-erosive and non-deforming, although Type 2 can persist for years independently of bowel activity.
Which extra-intestinal manifestation of IBD tracks disease activity?
Erythema nodosum and peripheral arthritis parallel bowel activity, while pyoderma gangrenosum, uveitis and primary sclerosing cholangitis follow their own course.